|
INFERTILITY
SECONDARY TO OVULATION DISORDERS
1. Check JH,
Rakoff AE, Roy BK: Induction of ovulation with combined glucocorticoid
and clomiphene citrate therapy in a minimally hirsute woman.
J Reprod Med 19:159-160, 1977.
2. Check JH:
Emotions and infertility. Mind and Medicine, Vol 6, No. 2,
Feb., 1979.
3. Check JH,
Adelson HG: Improved fertility in normoprolactinemic women with
ovulation defects treated with bromocriptine. Infertility 4:37-48,
1981.
4. Check JH,
Goldberg BB, Kurtz A, Adelson HG, Dietterich C: Serum estradiols
versus pelvic sonography in monitoring hMG therapy. Int J Fertil
30:61-63, 1985.
5. Check JH,
Wu CH, Goldberg BB, Kurtz A, Adelson HG: High-dose estrogen to
prevent premature spontaneous ovulation during hMG therapy: Two
case reports. Infertility 7:45-52, 1984.
6. Check JH,
Goldberg BB, Kurtz A, Adelson HG, Rankin A: Pelvic sonography
to help determine the appropriate therapy for luteal phase defects.
Int J Fertil 29:156-158, 1984.
7. Check JH,
Chase JS, Adelson HG, Dietterich C: New approaches to the diagnosis
and therapy of the luteinized unruptured follicle syndrome.
Int J Fertil 30:29-32, 1986.
8. Check JH,
Chase J: Ovulation induction in hypergonadotropic amenorrhea
with estrogen and human menopausal gonadotropin therapy. Fertil
Steril 42:919-922, 1984.
9. Check JH,
Wu CH, Gocial B, Adelson HG: Severe ovarian hyperstimulation
syndrome from treatment with urinary follicle stimulating hormone:
Two cases. Fertil Steril 43:317-319, 1985.
10. Check
JH, Chase JS: Ovarian pregnancy with a contralateral corpus luteum:
Case report. Am J Obstet Gynecol 154:155-156, 1986.
11. Check
JH, Chase JS, Rankin A, Teichman M: Abortion risk in patients
with ovulatory defects once viability is confirmed sonographically.
Infertility 8:195-200, 1985.
12. Check
JH: Use of bromocriptine in mildly hyperprolactinemic women with
follicular maturation defects. Advances In Therapy 2(6), 1985.
13. Check
JH, Chase JS, Adelson HG, Teighman M, Rankin A: The efficacy
of progesterone in achieving successful pregnancy: I. Prophylactic
use during luteal phase in anovulatory women. Int J Fertil
32:135-138, 1987.
14. Check
JH, Adelson HG: The efficacy of progesterone in achieving successful
pregnancy: II, in women with pure luteal phase defects. Int
J Fertil 32:139-141, 1987.
15. Check
JH: Hyperprolactinemia and luteal phase defects. Prolactin
Disorders: Highlights of a National Symposium. Sandoz Pharmaceuticals
Corporation, U.S.A., 9/26/86.
16. Check
JH, Nowroozi K, Wu CH, Adelson HG, Lauer C: Ovulation-inducing
drugs versus progesterone therapy for infertility in patients with
luteal phase defects. Int J Fertil 33(4):252-256, 1988.
17. Check
JH, Nowroozi K, Wu CH, Adelson HG, Lauer C: The importance of
luteal phase deficiency as a cause of infertility in a private practice
- A preliminary report. Infertility 10:111-120, 1987.
18. Check
JH, Wu CH, Adelson HG: Bromocriptine versus progesterone therapy
for infertility related to luteal phase defects in hyperprolactinemic
patients. Int J Fertil 34(3):209-214, 1989.
19. Check
JH, Wu CH, Check ML: The effect of leuprolide acetate in aiding
induction of ovulation in hypergonadotropic hypogonadism: A case
report. Fertil Steril 49(3):542-543, 1988.
20. Check
JH, Chase JS, Nowroozi K, Wu CH, Chern R: Clinical evaluation
of the PipelleR endometrial suction curette (Pipelle de CornierTM)
for timed endometrial biopsies. J Reprod Med 34(3):218-220,
1989.
21. Check
JH: Progesterone therapy for luteal phase deficiency. Medical
aspects of human sexuality 22(8):89-90, 1988.
22. Check
JH, Wu CH: Ovulation induction in women with ovarian failure
with high dose estrogen and gonadotropin therapy. Life Science
Advances - Experimental and Clinical Endocrinology 7:169-171, 1988.
23. Check
JH, Wu CH, Epstein R, Adelson HG, Davies E, Liss J, Stern J, Vetter
B: Effect of age on the success of therapy for infertility.
Infertility 12(2):63-71, 1989.
24. Check
JH, Adelson HG, Dietterich C, Stern J: Pelvic sonography can
predict ovum release in gonadotropin-treated patients as determined
by pregnancy rate. Hum Reprod 5(3):234-236, 1990.
25. Check
JH, Dietterich C, Houck M: Ipsilateral versus contralateral ovary
selection of dominant follicle in succeeding cycle. Obstet Gynecol
77(2):247-249, 1991.
26. Check
JH, Nowroozi K, Check ML, Vetter B: Correlation of serum progestagen
associated endometrial protein levels with endometrial biopsies,
serum steroid levels, and therapy for luteal phase defects. Hum
Reprod 6(4):511-514, 1991.
27. Check
JH, Chase JS, Nowroozi K, Dietterich CJ: Premature luteinization
- Treatment and incidence in natural cycles. Hum Reprod 6:190-193,
1991.
28. Check
JH, Vaze MM, Raikar RS, Nowroozi K, Joshi SG, Epstein R, Vetter
B: Late luteal phase progestagen-dependent endometrial protein
levels in women with in phase biopsies - Can low levels predict
a subfertile group? Int J Fertil 37:350-353, 1992.
29. Shanis
B, Check JH, Bollendorf A: Adverse effect of clomiphene citrate
on sperm morphology. Arch Androl 27:109-111, 1991.
30. Check
JH, Adelson HG, Stern J, Lauer C: Influence of serum progesterone
levels at the time of hCG on the release of ova during hMG cycles.
Int J Fertil 37:103-105, 1992.
31. Check
JH: Letter-to-the-editor: Ipsilateral versus contralateral ovary
selection of dominant follicle in succeeding cycle. Obstet Gynecol
77:969-970, 1991.
32. Check
JH, Vaze M, Raikar R, Nowroozi K, Joshi S, Epstein R, Vetter B:
Fertility better correlates with higher levels of progestogen-dependent
endometrial protein. Infertility 13:131-136, 1990.
33. Check
JH, Dietterich C, Nowroozi K, Wu CH: Comparison of various therapies
for the luteinized unruptured follicle (LUF) syndrome. Int J
Fertil 37:33-40, 1992.
34. Check
JH, Chase JS, Adelson HG, Lauer C, Schubert B: A conservative
treatment protocol with human menopausal gonadotropins aimed at
reducing multiple births. J Perinat Med 21:315-319, 1993.
35. Check
JH, Dietterich C, Lauer C, Lurie D: The effect of follicle-maturing
drugs on mid-cycle androgen levels in women with normal baseline
levels. Gynecologic Endocrinology 6:107-111, 1992.
36. Check
JH, Davies E, Adelson H: A randomized prospective study comparing
pregnancy rates following clomiphene citrate and human menopausal
gonadotropin therapy. Hum Reprod 7(6):801-805, 1992.
37. Check
JH, Dietterich C, Adelson HG: The effect of follicle maturing
drugs on side of ovulation in successive cycles. Hum Reprod
7(4):475-478, 1992.
38. Check
JH, Adelson H, Lurie D, Jamison T: The effect of the short follicular
phase on subsequent conception. Gynecol Obstet Invest 34:180-183,
1992.
39. Check
JH, Nazari A, Barnea ER, Weiss W, Vetter BH: The efficacy of
short-term gonadotrophin-releasing hormone agonists versus human
chorionic gonadotrophin to enable oocyte release in gonadotrophin
stimulated cycles. Hum Reprod 8:568-571, 1993.
40. Check
JH, Vetter BH, Weiss W: Comparison of hCG versus GnRH analog
in releasing oocytes following ultra low-dose gonadotropin stimulation.
Gynecol Endocrinol 7:115-122, 1993.
41. Shanis
B, Check JH: Efficacy of gonadotropin-releasing hormone agonists
to induce ovulation following low-dose human menopausal gonadotropin
stimulation. Recent Progress in Hormone Research, Proceedings
of the 1993 Laurentian Hormone Conference, Edited by C. Wayne Bardin,
Academic Press, Inc., Vol 50, pgs 483-486, 1995.
42. Check
JH: The role of progesterone in supporting implantation and preventing
early pregnancy loss. Implantation and Early Pregnancy in Humans
Edited by ER Barnea, JH Check, J Gedis Grudzinskas, T Maruo, The
Parthenon Publishing Group. Chapter 11, pages 137-160, 1994.
43. Check
JH, Dietterich C, Lurie D: The relationship of endometrial thickness
and echo patterns on pregnancy rates in patients with luteal phase
defects. Gynecol Obstet Invest 40:101-107, 1995.
44. Check
JH, Dietterich C, Lurie D: The effect of consecutive cycles of
clomiphene citrate therapy on endometrial thickness and echo pattern.
Obstet Gynecol 86(3):341-345, 1995.
45. Check
JH, Peymer M, Lurie D, Suryanarayan C: The relationship of early
follicular phase serum luteinizing hormone (LH) and pregnancy rates
in women with regular menses. Obstet Gynecol 87:291-296, 1996.
46. Check
JH: Letter to the editor RE: Progesterone, Impedance to blood
flow and luteal inadequacy? Fertil Steril 65:454-455, 1996.
47. Peymer
M, Check JH: Incidence of infertility: etiology, pregnancy/spontaneous
abortion rates according to age of female partner. ARTA 9:79-83,
1997.
48. Askari
HA, Check JH, Fine W, Lurie D: Mid-cycle steroidal levels after
ultra-low dose pure follicle-stimulating hormone stimulation versus
human menopausal gonadotropin stimulation in euestrogenic women
with follicular maturation defects. Endoc Prac 2(3):173-175,
1996.
49. Shanis
BS, Check JH: Relative resistance of a macroprolactinoma to bromocriptine
therapy during pregnancy. Gynecol Endocrinol 10(2):91-94, 1996.
50. Check
JH, Fine W: Similar pregnancy rates and spontaneous abortion
rates with treatment with low-dose hMG vs pure FSH in women with
luteal phase defects. Clinical Experimental Obstet Gynecol 24:5-7,
1997.
51. Check
JH, Nazari A, Kuhn R, Lauer C: Relationship of early follicular
phase sera follicle stimulating hormone and luteinizing hormone
levels as measured by a radioimmunoassay and an enzyme-linked immunosorbent
assay to number of oocytes retrieved. Clinical Experimental
Obstet Gynecol 23(2):83-86, 1996.
52. Check
JH: Low-dose gonadotrophin stimulation for luteal phase defects
- Does absence of LH help pregnancy rates? Delaware Medical
Journal 68(4):223-226, 1996.
53. Check
JH, Cohen R, Peymer M, Resnick M, Suryanarayan C: Correlation
of basal menses CA-125 levels and 6 month pregnancy rates in women
undergoing treatments for infertility without assisted reproductive
methods. Am J Reprod Immunol 37:315-319, 1997.
54. Check
JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH: Evidence that
the expression of progesterone-induced blocking factor by maternal
T-lymphocytes is positively correlated with conception. Am J
Reprod Immunol 38:6-8, 1997.
55. Check
JH, Szekeres-Bartho J, O’Shaughnessy A: Progesterone induced
blocking factor seen in pregnancy lymphocytes soon after implantation.
Am J Reprod Immunol 35:277-280, 1996.
56. Check
JH, Szekeres-Bartho J, Nazari P, Katz Y, Check ML: A corpus luteum
is not a prerequisite for the expression of progesterone induced
blocking factor by T-lymphocytes a week after implantation.
J Assist Reprod Genet 18:603-607, 2001.
57. Check
JH, Check ML: A case report demonstrating that follicle maturing
drugs may create an adverse uterine environment even when not used
for controlled ovarian hyperstimulation. Clin Exp Obst Gyn 28:217-218,
2001.
58. Check
JH: Cryptic infertility and therapeutic options. Clin Exp
Obst Gyn 28:205-211, 2001.
59. Check
JH: Progesterone therapy versus follicle maturing drugs - possible
opposite effects on embryo implantation. Clin Exp Obst Gyn 29:5-10,
2002.
60. Check
JH, Check ML: Evidence that failure to conceive despite apparent
correction of ovulatory defects by follicle-maturing drugs may be
related to premature trophoblast invasion. Med Hypoth 59:385-388,
2002.
61. Check
JH, Gandica R, Dietterich C, Lurie D: Evaluation of a nonhomogeneous
endometrial echo pattern in the midluteal phase as a potential factor
associated with unexplained infertility. Fertil Steril 79:590-593,
2003.
62. Check JH,
Dietterich C, Check ML, Katz Y: Successful delivery despite
conception with a maximal endometrial thickness of 4mm. Clin Exp Obst Gyn
30:93-94, 2003.
63. Check JH,
Liss JR, Shucoski K, Check ML: Effect of short follicular phase
with follicular maturity on conception outcome. Clin Exp Obst Gyn
30:195-196, 2003.
64. Check JH:
Ovulation disorders: Part I Anovulation associated with
estrogen deficiency. Clin Exp Obst Gyn
34:5-8, 2007.
65. Check JH:
Ovulation disorders: Part II Anovulation associated with
normal estrogen. Clin Exp Obst Gyn
34:69-72, 2007.
|
